Matrix Private Capital Group LLC Bristol Myers Squibb CO Transaction History

Matrix Private Capital Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $4,245 - $5,027	-62 Reduced 1.82%	3,349 $240,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $0 - $230	-3 Reduced 0.09%	3,411 $242,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $217 - $239	3 Added 0.09%	3,414 $265,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $122 - $147	2 Added 0.06%	3,411 $251,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $182,824 - $213,130	3,409 New	3,409 $213,000
Q3 2021 Feb 22, 2022	SELL	$59.17 - $69.31 $182,243 - $213,474	-3,080 Closed	0 $0
Q2 2021 Feb 22, 2022	BUY	$61.91 - $67.42 $190,682 - $207,653	3,080 New	3,080 $206,000
Q4 2020 Feb 22, 2022	SELL	$57.74 - $65.43 $247,762 - $280,760	-4,291 Closed	0 $0
Q2 2020 Feb 22, 2022	SELL	$54.82 - $64.09 $4,275 - $4,999	-78 Reduced 1.79%	4,291 $252,000
Q1 2020 Feb 22, 2022	SELL	$46.4 - $67.43 $68,161 - $99,054	-1,469 Reduced 25.16%	4,369 $244,000
Q4 2019 Feb 22, 2022	BUY	$49.21 - $64.19 $287,287 - $374,741	5,838 New	5,838 $375,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Matrix Private Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Matrix Private Capital Group LLC with notifications on news.